Travelling with Aspergillosis: A Comprehensive Guide to Safe and Stable Travel

This guide is for people living with:

• Chronic Pulmonary Aspergillosis (CPA)
• Allergic Bronchopulmonary Aspergillosis (ABPA)
• Severe asthma (including fungal sensitisation)
• Bronchiectasis
• Fibrotic or structurally abnormal lung disease

Most people with stable disease can travel successfully. The goal is not restriction — it is risk reduction through preparation, environmental awareness, and early action if symptoms change.

---

Contents

• 1. Understanding Travel Risk in Aspergillosis
• 2. Coordinating With Your Medical Team
• 3. Assessing Stability Before Travel
• 4. Choosing a Destination: Environmental Determinants
• 5. Regional Risk Patterns Explained
• 6. Air Pollution & AQI Monitoring
• 7. Heat, Humidity & Hydration Physiology
• 8. Travel Insurance & Disclosure
• 9. Medication Planning & Contingency Prescriptions
• 10. Specific Considerations for Azole Antifungals
• 11. Air Travel: Physiology & Fit-to-Fly
• 12. Cabin Dryness & Post-Flight Irritation
• 13. Travelling with Oxygen
• 14. Accommodation Risk Reduction
• 15. High-Spore & Dust Exposure Environments
• 16. Infection Prevention
• 17. Haemoptysis Planning
• 18. Red Flag Symptoms
• 19. Advanced Planning Checklist

---

1. Understanding Travel Risk in Aspergillosis

Travel risk arises from four domains:

1. Structural lung vulnerability (cavities, fibrosis, bronchiectasis)
2. Inflammatory instability (ABPA activity, asthma control)
3. Environmental exposure (humidity, dust, pollution)
4. Healthcare accessibility (if deterioration occurs)

Travel is usually safe when disease is stable and exposures are predictable.

---

2. Coordinating With Your Medical Team

Respiratory Clinic

• Review recent imaging (particularly in CPA)
• Assess haemoptysis history
• Consider fit-to-fly testing if oxygen saturation borderline
• Discuss standby rescue medication

GP

• Ensure medication supply exceeds travel duration
• Provide updated medication summary
• Support vaccination review
• Assist with insurance documentation

---

3. Assessing Stability Before Travel

Delay travel if within 4–6 weeks of:

• Significant haemoptysis
• Escalating breathlessness
• Recent hospital admission
• New antifungal initiation

Stable inflammatory markers and symptom plateau are reassuring.

---

4. Choosing a Destination: Environmental Determinants

Key determinants:

• Humidity: promotes indoor mould growth
• Flood history: water damage increases fungal load
• Air pollution: triggers bronchospasm
• Dust burden: irritates inflamed airways
• Healthcare infrastructure: safety net if unwell

---

5. Regional Risk Patterns Explained

Lower Overall Respiratory Stress

• Scandinavia
• New Zealand
• Canada (outside wildfire season)

Cooler climates limit mould growth; strong building codes reduce damp housing.

Moderate Risk

• Mediterranean Europe

Generally safe when stable; monitor wildfire smoke and heat stress.

Higher Respiratory Stress

• Tropical monsoon climates
• Flood-prone regions
• Highly polluted megacities
• Dust storm zones

Humidity increases fungal proliferation; particulate pollution worsens airway inflammation.

---

---

6. Air Pollution & AQI Monitoring

Air pollution can exacerbate cough, bronchospasm, breathlessness and fatigue in people with chronic lung disease. In some urban environments, pollution may pose a greater day-to-day risk than fungal exposure.

The most widely used measure of air quality is the Air Quality Index (AQI), which combines several pollutants into a single score.

---

Key Pollutants That Matter in Lung Disease

• PM2.5 – fine particulate matter small enough to penetrate deep into the lungs
• PM10 – larger inhalable particles
• Ozone (O₃) – irritates airways, especially in heat
• Nitrogen dioxide (NO₂) – associated with traffic pollution

PM2.5 is particularly important in aspergillosis and severe asthma because it can:

• Trigger airway inflammation
• Increase mucus production
• Worsen bronchospasm
• Reduce exercise tolerance

---

Reliable Air Quality Monitoring Resources

These sites provide real-time data and forecasts:

• World Air Quality Index (WAQI)
  https://waqi.info
  Interactive global map with live AQI data for cities worldwide.
• IQAir (AirVisual)
  https://www.iqair.com
  Detailed pollutant breakdowns, 7-day forecasts and wildfire smoke tracking.
• UK Daily Air Quality Index (DEFRA)
  https://uk-air.defra.gov.uk
  Official UK monitoring network with health advice bands.

These platforms also offer mobile apps, which are useful for checking conditions while travelling.

---

How to Interpret AQI in Practical Terms

AQI	Category	Practical Advice for Lung Conditions
0–50	Good	Ideal conditions for outdoor activity
51–100	Moderate	Usually safe; monitor symptoms
101–150	Unhealthy for sensitive groups	Reduce strenuous outdoor activity; consider indoor plans
151–200	Unhealthy	Limit time outdoors; avoid exertion
200+	Very Unhealthy/Hazardous	Stay indoors with filtered air if possible

For many patients with CPA, ABPA or severe asthma, an AQI above 100 warrants caution. Above 150, limiting outdoor exposure is advisable.

---

Wildfire Smoke

Wildfire smoke contains high concentrations of PM2.5 and organic particulates. Even patients who are stable at home may experience:

• Increased cough
• Chest tightness
• Increased sputum production
• Fatigue

If travelling during wildfire season:

• Check AQI daily
• Plan indoor activities when levels are elevated
• Use air-conditioned or filtered indoor environments
• Carry rescue inhalers

---

Urban Pollution vs Rural Dust

Urban areas are more affected by traffic-related pollutants (NO₂, PM2.5), while rural or desert areas may present dust exposure. Both can aggravate inflamed airways.

The risk is cumulative. Short exposure is usually tolerated; prolonged high-level exposure increases the likelihood of symptom flare.

---

Key principle: checking AQI before and during travel is one of the simplest and most effective risk-reduction steps for people with chronic lung disease.

---

7. Heat, Humidity & Hydration Physiology

Hot climates place additional physiological stress on people with chronic lung disease.

Why Heat Matters

In warm environments, the body increases sweating and respiratory water loss to regulate temperature. This leads to:

• Increased insensible fluid loss (fluid lost through breathing and skin)
• Reduced plasma volume if intake is inadequate
• Thickening of airway secretions

In bronchiectasis and chronic pulmonary aspergillosis (CPA), mucus clearance is already impaired. Dehydration increases mucus viscosity, making sputum:

• Harder to expectorate
• More likely to stagnate in damaged airways
• Potentially more prone to secondary infection

Patients may notice thicker sputum, increased cough, or chest tightness in hot weather.

---

Humidity: Helpful or Harmful?

Humidity has mixed effects:

• Moderate humidity can help prevent airway drying.
• High humidity can increase environmental mould growth, particularly indoors if ventilation is poor.

In tropical or monsoon climates, poorly ventilated buildings may have higher fungal spore burdens due to damp conditions.

---

Heat, Fatigue & Breathlessness

Heat increases cardiovascular demand. The heart works harder to dissipate heat, which can:

• Increase perceived breathlessness
• Increase fatigue
• Reduce exercise tolerance

This does not necessarily indicate worsening lung disease — but it can feel similar.

---

Hydration Strategy

Practical recommendations:

• Begin hydrating the day before travel
• Drink fluids regularly rather than waiting for thirst
• Aim for pale straw-coloured urine
• Increase intake during flights and hot excursions

Limit:

• Excess alcohol (diuretic effect)
• High caffeine intake

---

Additional Practical Measures

• Plan outdoor activity early morning or evening
• Rest during peak heat (midday)
• Use air-conditioned environments when available
• Continue airway clearance routines while travelling

---

Key principle: in chronic lung disease, hydration supports mucus clearance and reduces avoidable exacerbation risk during hot weather.

---

8. Travel Insurance & Full Medical Disclosure

Travel insurance is not a formality — it is a critical safety net for people with chronic lung disease.

When purchasing insurance, you must declare all pre-existing medical conditions. This typically includes:

• Chronic Pulmonary Aspergillosis (CPA)
• Allergic Bronchopulmonary Aspergillosis (ABPA)
• Severe asthma
• Bronchiectasis
• Pulmonary fibrosis
• Long-term steroid therapy
• Adrenal insufficiency (if present)
• Oxygen use (even if only occasional)

Why Full Disclosure Matters

If you fail to declare a relevant condition, the insurer may:

• Refuse to cover medical treatment abroad
• Decline repatriation costs
• Refuse to reimburse cancelled flights or accommodation
• Invalidate the entire policy

This applies even if the emergency appears unrelated. Insurers may review your full medical history during a claim.

---

What Insurers Typically Ask

You may be asked:

• Have you been hospitalised in the past 12 months?
• Have you had medication changes recently?
• Have you had haemoptysis?
• Are you awaiting tests or investigations?
• Are you on long-term steroids?

Answer these questions carefully and honestly.

---

Policies and Stability

Some insurers will decline cover if:

• You have been hospitalised recently
• You are awaiting investigations
• Your condition is considered unstable

This is another reason to travel during a period of clinical stability.

---

European Travel (UK Patients)

If travelling within Europe, ensure you carry:

• Your GHIC (Global Health Insurance Card)

However, GHIC does not replace travel insurance. It may not cover:

• Private healthcare
• Mountain rescue
• Repatriation to the UK

---

Practical Tips

• Purchase insurance as soon as you book travel
• Keep written confirmation of declared conditions
• Carry the insurer’s emergency contact number with you
• Inform the insurer early if you require hospital care abroad

---

In summary: full disclosure protects you. Insurance is only effective if the insurer understands your medical background from the outset.

---

9. Medication Planning & Contingency Prescriptions

• Carry 1–2 weeks extra supply
• Bring medications in original packaging
• Carry clinic letter
• Consider written rescue plan

---

10. Specific Considerations for Azole Antifungals

Azoles have significant drug–drug interactions.

• Inform any clinician abroad you are taking an azole
• Avoid grapefruit
• Be aware of sun sensitivity (voriconazole)
• Take itraconazole with food

---

---

11. Air Travel: What Actually Happens in the Cabin?

Commercial aircraft cabins are pressurised to simulate an altitude of approximately 6,000–8,000 feet (1,800–2,400 metres).

This means the partial pressure of oxygen is lower than at sea level. For healthy individuals this causes only a small drop in oxygen saturation (typically 3–4%).

Are Most People with Aspergillosis OK to Fly?

Yes — most stable patients fly without difficulty.

People who are:

• Clinically stable
• Not oxygen-dependent
• Without recent haemoptysis
• With resting oxygen saturations ≥95%

generally tolerate commercial flights well, including medium and long-haul travel.

Many patients report anxiety before their first flight after diagnosis, but in stable disease, significant problems are uncommon.

---

Who Should Consider Fit-to-Fly Testing?

Assessment may be appropriate if you have:

• Resting oxygen saturation consistently below 95%
• Advanced pulmonary fibrosis
• Extensive cavitation
• Significant breathlessness at minimal exertion
• Recent clinical deterioration

The test commonly used is a Hypoxic Challenge Test (HCT), which simulates cabin oxygen conditions to determine whether supplemental oxygen is required during flight.

Where would I have a Hypoxic Challenge Test (HCT)?

In the UK, a Hypoxic Challenge Test is usually arranged through a hospital respiratory physiology department.

You cannot book this test directly. It must be requested by:

• Your respiratory consultant or clinic, or
• Occasionally your GP (who would refer you to a hospital service)

The test is typically performed in:

• A hospital lung function laboratory
• A respiratory physiology unit
• A specialist respiratory centre

During the test, you breathe a gas mixture containing a lower oxygen concentration (usually around 15%) to simulate aircraft cabin conditions. Your oxygen saturation is monitored continuously. If levels fall below safe thresholds, in-flight oxygen may be recommended.

Do Most People Need This Test?

No. Many stable patients with normal resting oxygen saturation (typically ≥95%) do not require hypoxic challenge testing.

The test is generally considered if you:

• Have resting oxygen saturation below 95%
• Have advanced pulmonary fibrosis
• Are already using oxygen
• Have significant exertional desaturation

If you are unsure, ask your respiratory team whether assessment is appropriate for you.

---

Symptoms During Flight: What Is Normal?

Mild symptoms that can occur in stable patients include:

• Slight increase in breathlessness on walking the aisle
• Fatigue
• Dry cough (often due to low humidity)

These are usually temporary and not dangerous.

Severe symptoms (marked breathlessness at rest, chest pain, dizziness, confusion) are uncommon and require crew notification.

---

Anxiety vs Physiological Breathlessness

It is very common for people with chronic lung disease to experience heightened awareness of their breathing during flights. The enclosed environment, reduced cabin pressure and awareness of altitude can all increase anxiety.

Anxiety-related breathlessness typically presents as:

• A sensation of not getting a “satisfying” breath
• Chest tightness without wheeze
• Rapid breathing (hyperventilation)
• Tingling in fingers or lips
• Light-headedness

Hyperventilation lowers carbon dioxide levels in the blood. This can cause dizziness, tingling and a feeling of air hunger — even when oxygen levels are normal.

Physiological hypoxia (true low oxygen levels) is less common in stable patients who have been assessed as fit to fly. When it occurs, it is more likely in those with advanced fibrosis, low baseline oxygen saturations, or recent instability.

Features more suggestive of physiological compromise include:

• Persistent breathlessness at rest
• Worsening cyanosis (bluish lips or fingers)
• Marked fatigue or confusion
• Objective low oxygen saturation if measured

For patients who have undergone fit-to-fly assessment and been cleared to travel, significant in-flight hypoxia is uncommon.

Practical Strategies

• Use slow, paced breathing (e.g. inhale for 4 seconds, exhale for 6 seconds)
• Focus on extended exhalation to reduce hyperventilation
• Keep shoulders relaxed and posture upright
• Avoid repeatedly “checking” your breathing
• Remind yourself that mild symptoms are common and expected

Understanding the difference between anxiety-related breathlessness and true hypoxia can significantly reduce distress during flight.

---

Deep Vein Thrombosis (DVT) Risk

Chronic lung disease does not automatically increase DVT risk, but long-haul immobility does.

General advice:

• Move legs regularly
• Stay hydrated
• Avoid excess alcohol

---

12. Cabin Dryness & Post-Flight Airway Irritation

Cabin humidity is typically 10–20% (normal indoor comfort is 40–60%).

Low humidity can:

• Dry airway lining
• Reduce mucociliary clearance
• Thicken secretions
• Trigger cough or mild bronchospasm

This is often why people feel they have “caught a cold” the day after flying. In most cases, it is airway irritation rather than infection.

How to Reduce Dryness Effects

• Hydrate well before and during flight
• Limit alcohol and caffeine
• Use isotonic saline nasal spray
• Continue preventer inhalers
• Keep rescue inhaler accessible
• Avoid direct overhead air vents blowing onto your face
• Consider mask use — masks increase humidity of inhaled air

Symptoms typically settle within 24–48 hours.

---

When to Seek Advice After Flying

Seek medical advice if you develop:

• Progressively worsening breathlessness
• Persistent fever
• Significant haemoptysis
• Chest pain

In stable patients, serious in-flight deterioration is uncommon.

---

12. Cabin Dryness & Post-Flight Irritation

Cabin humidity is 10–20%.

Dry air:

• Reduces mucociliary clearance
• Thickens secretions
• Triggers cough
• Irritates airways

Hydration and saline sprays reduce symptoms. Post-flight irritation commonly lasts 24–48 hours and does not necessarily indicate infection.

---

13. Travelling with Oxygen

Confirm airline device approval and battery duration. Plan well in advance.

---

14. Accommodation Risk Reduction

Request:

• Hard flooring
• No damp odour
• No renovation dust
• Pet-free rooms

Chains Often Reported as Allergy-Conscious

• Hyatt
• Hilton
• Marriott
• Scandic
• Premier Inn

Newer business hotels often have better HVAC filtration.

---

15. High-Spore & Dust Exposure Environments

• Compost handling
• Construction sites
• Flood-damaged buildings
• Agricultural dust

Avoid heavy inhalation exposure.

---

16. Infection Prevention

• Hand hygiene
• Avoid close contact with visibly unwell individuals
• Maintain vaccination schedule

---

17. Haemoptysis Planning

If you have a history of haemoptysis:

• Know your previous pattern
• Carry clinic contact details
• Seek urgent care if volume increases significantly

---

18. Red Flag Symptoms

• Increasing breathlessness
• New or worsening haemoptysis
• Persistent fever
• Severe chest pain

---

19. Advanced Planning Checklist

• Travel when stable
• Plan with GP and respiratory clinic
• Carry documentation
• Monitor AQI
• Hydrate on flights
• Avoid damp & heavy dust
• Know red flags

With preparation, most people with stable aspergillosis travel safely and successfully.

---

by GAtherton